ISCRIVITI ALLA NEWSLETTER
The company name Phyllon derives from the ancient Greek word “filos”, meaning friendly. We are aiming to incorporate this in our company philosophy and our team is living by this philosophy. We emphasize friendly, open and respectful communication with each other – each and every day.

Phyllon was founded in 2016, in Graz (AUT), to produce and distribute the OSeeT Pharma 1D, a system based on Optical Coherence Tomography (OCT). The combination of expertise in technology and pharmaceutical processes enables us to offer a unique instrument to ensure high quality of your coating or other pharmaceutical product.
Phyllon and the OSeeT are regularly involved in research projects, for example the following ones:
• Starting in 2020, OSeeT was a big part of an FDA-funded project for Next-Generation Pharma Technology which was led by RCPE in Graz (AUT).
• Frequently, we are also part of funded COMET K1 projects together with RCPE, as well as other industrial and research partners in the pharmaceutical field. These projects aim to bring science and innovative ideas closer to industry.
As a company specializing in the pharmaceutical field and other industries, we are aiming to improve quality control for our customers.
We are constantly trying to improve our products and knowledge by finding innovative applications and software solutions for our technology.
2016
Prototype of OSeeT for the pharmaceutical industry
2018
First commercial version of OSeeT for the pharmaceutical industry
2020
First in-line installation of OSeeT in a production coater for tablet coating thickness measurement/monitoring
2021
In-line installation of OSeeT in a fluid bed coater (pellet coating monitoring)
2022
New software algorithm prototype for indirect measurement of coatings containing scattering pigments
2023
Finalisation of an Ultra-High Resolution (UHR) OCT prototype with a resolution of down to about only 4 µm